CEACAM5 and malignant colon neoplasm: At Duke Cancer Institute, Morse et al. evaluated the effectiveness of a CEA RNA-pulsed DC cancer vaccine and RFS in patients with resected liver metastases from colon cancer.376 The CEA RNA-pulsed DC cancer vaccine used DCs to deliver an RNA encoding the CEA protein.